Combined serum biomarkers in non-invasive diagnosis of non-alcoholic steatohepatitis
作者单位：Department of Pathology and HepatologyBeijing 302 Hospital Department of Clinical TrialBeijing 302 Hospital
会议名称：《中华医学会第十三次全国感染病学术会议》
会议日期：2014年
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
摘 要：Background&Aims Non-alcoholic Fatty Liver Diseases(NAFLD),especially its critical stage of nonalcoholic steatohepatitis(NASH),has become one of the most important public health issues *** liver biopsy remains the Golden Standardfor diagnosing NASH,noninvasive diagnostic methods are eagerly needed to reduce the need for invasive biopsy and risk to *** study aims at testing the accuracy of cytokeratin-18(CK-18)fragment,fibroblast growth factor 21(FGF21),interleukin 1 receptor antagonist(IL-